It doesn’t matter how you slice or dice the dyslipidemia pie As shown in this paper as well as multiple prior publications, ascvd risk is directly associated with presents and burden of CAC Doesn’t matter if you have high/low LDL or HDL It’s as simple as that 👇

The superior performance of high-dose quadrivalent influenza vaccines over standard-dose quadrivalent vaccines is consistent whether or not a patient has #CKD, according to a secondary analysis of the DANFLU-1 trial presented at #ESCCongress and simultaneously published in

Khurram Nasir Yes, in fact the closest proxy to disease is CACS not cholesterol…

Despite excellent data from Europe Denmark) #ESCCongress2024 #ESCGuidelines again ignore their own local insights on the #PowerOfZero #CAC reclassifying pretest probability for use of downstream testing Maybe in next 4 yrs 🤷🏻

despite extensive data from Europe, including Denmark-> nearly 1 in 2 those considered for CCTA have a CAC0, reclassified risk is extremely low, and can be used as to lower pretest risk-> avoid advanced imaging What’s the point if data going to be ignored? #ESCCongress2024

The Lebanese Idol Dr WilliamZoghbi at the ESC Lebanese Society of Cardiology booth! Proud_to_be_lebanese! European Society of Cardiology #cardiology #Master_Of_Cardiology #Lebanese_Society_of_cardiology #Lebanon #USA

Editors’ Insights: Fascinating new research suggests short-term exposure to cold snaps may increase myocardial infarction risk with a 2-6 day lag time: bit.ly/3XmLCFS #JACC #ESCCongress #cvMI

Heterogeneity exists in subclinical ath across LDL-C, CAC and estimated 🫀 risk levels. The value of CCTA in risk-stratifying asymptomatic 👫 could be explored further 🔗atherosclerosis-journal.com/article/S0021-… Khurram Nasir Reed Mszar Miguel Cainzos-Achirica Michael D. Shapiro Jonathan Fialkow Sadeer Al-Kindi, MD

RESHAPE-HF2 out JACC Journals & NEJM - joining the ranks of the pivotal COAPT & MITRAFR, and possibly acting as a tie-breaker. Check out our editorial proposing an LV volume-based framework to reconcile the 3 trials #miltonpacker Raj Makkar Paul Grayburn jacc.org/doi/10.1016/j.…

Congratulations to Dr. Rishi Wadhera on receiving 2 R01 grants totaling $6 million from the NIH for research focused on leveraging policy to advance cardiovascular health in United States.

Amazing news Congrats Rishi Wadhera, MD MPP 👏👏

Khurram Nasir Hany Ragy Agree Khurram Nasir - not necessary. Money could have been better spent on questions we don’t know the answer to.

‼️Just published‼️ Patients with Rheumatologic Diseases have ⬆️ rates of atherosclerotic disease risk factors including DM, HTN, HLD, Obesity. It is SO important for these patients to have intensive risk factor management to prevent CVD associated morbidity and mortality! 🫀🫶